Home » Topics » Disease categories and therapies » Infection

Infection
RSS

CMV NeutraGAM development update

May 17, 1996

Interferon Sciences reacquires U.S. and Canadian marketing rights for interferon product

May 17, 1996

IDEC receives NIAID grant to develop MAbs for RSV

May 17, 1996

Nippon Shoji to collaborate on nisin development in Pacific rim countries

May 17, 1996

Triazole antifungals reported by Tanabe

May 17, 1996

Takeda reports oral cephem antibacterials

May 17, 1996

Reticulose begins clinical testing for HPV indication

May 10, 1996

Sporanox-Pulse now available in U.K.

May 10, 1996

Vical/Merck DNA influenza vaccine moves ahead to clinical testing

May 10, 1996

Mentax clinical results in athlete's foot presented at conference

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.